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BRCC36 is a Zn2+-dependent deubiquitinating en-
zyme (DUB) that hydrolyzes lysine-63-linked ubiqui-
tin chains as part of distinct macromolecular com-
plexes that participate in either interferon signaling
or DNA-damage recognition. The MPN+ domain pro-
tein BRCC36 associates with pseudo DUB MPN–
proteins KIAA0157 or Abraxas, which are essential
for BRCC36 enzymatic activity. To understand the
basis for BRCC36 regulation, we have solved the
structure of an active BRCC36-KIAA0157 hetero-
dimer and an inactive BRCC36 homodimer. Struc-
tural and functional characterizations show how
BRCC36 is switched to an active conformation by
contacts with KIAA0157. Higher-order association
of BRCC36 and KIAA0157 into a dimer of hetero-
dimers (super dimers) was required for DUB activity
and interaction with targeting proteins SHMT2 and
RAP80. These data provide an explanation of how
an inactive pseudo DUB allosterically activates a
cognate DUB partner and implicates super dimeriza-
tion as a new regulatory mechanism underlying
BRCC36 DUB activity, subcellular localization, and
biological function.
INTRODUCTION
Ubiquitin-mediated signal transduction depends on a balance
between tightly regulated ubiquitin ligase and deubiquitinating
enzyme (DUB) activities (Komander and Rape, 2012; Komander
et al., 2009). Additional layers of control occur at the level of
ubiquitin binding domain containing proteins that influence the970 Molecular Cell 59, 970–983, September 17, 2015 ª2015 The Autlocalization of ubiquitin-directed enzymatic activity to specific
subcellular compartments. Polyubiquitin chains linked through
lysine 63 of ubiquitin (K63-Ub) are synthesized by specific E2
ubiquitin ligase enzyme pairs (Ubc13–Uev1A) and can be selec-
tively recognized by ubiquitin binding domains (e.g., tandem
UIMs in RAP80 and NZF domains in TAB2 [Husnjak and Dikic,
2012; Sato et al., 2009; Sims and Cohen, 2009; Sobhian et al.,
2007]) and hydrolyzed in a linkage-selective manner by specific
deubiquitinating enzymes (Eletr and Wilkinson, 2014). K63-Ub
chains are utilized in signaling events in both the cytoplasm
and nucleus and do not target proteins for degradation by the
proteasome.
BRCC36 is the catalytic subunit responsible for the majority
of K63-Ub-specific DUB activity in the cytoplasm and in the
nucleus as part of two distinct macromolecular assemblies
characterized by the presence of either of the MPN– pseudo
DUB proteins KIAA0157 or Abraxas (Cooper et al., 2009; Dong
et al., 2003; Sobhian et al., 2007). MERIT40 and BRCC45 are
common subunits to both complexes. The Abraxas complex
(ARISC) functions in DNA repair and breast cancer suppression,
while the BRCC36 isopeptidase complex (BRISC) promotes
interferon-dependent responses by deubiquitinating and stabi-
lizing the type I interferon receptor, IFNAR1. Both BRCC36
complexes demonstrate tightly regulated DUB activity involving
protein-protein interactions with their pseudo DUB subunits and
with targeting proteins SHMT2 or RAP80. The latter two target
the complexes to K63-Ub chains that are synthesized locally in
response to cytokine receptor activation for BRISC or DNA dou-
ble-strand breaks (DSBs) for ARISC (Kim et al., 2007; Sobhian
et al., 2007; Wang et al., 2007; Zheng et al., 2013).
BRCC36 consists of a functional metalloprotease JAMM/
MPN+ domain followed by a predicted coiled-coil region impli-
cated in protein-protein interactions. MPN+ domain DUBs share
a common fold architecture and catalytic mechanism for pep-
tide bond cleavage involving coordination of a Zn2+ ion by two
histidines and one aspartate, an active site glutamic acid thathors
delivers a water molecule for hydrolysis of isopeptide bonds, and
an active site serine residue thought to stabilize the tetrahedral
transition state intermediate in a similar mechanism to that
of Zn metalloproteases subtilisin and thermolysin (Ambroggio
et al., 2004; Tran et al., 2003). MPN+ DUBs are implicated in
cleaving ubiquitin chains from unfolded proteins (e.g., RPN11
subunit within the proteasome), while others show specificity
for hydrolysis of the ubiquitin-like protein Nedd8 (e.g., CSN5
cleaving Nedd8 from Cullins), and, finally, several are highly se-
lective for particular chain linkages (e.g., AMSH and BRCC36).
The archetype family member AMSH-LP cleaves K63 linked
ubiquitin chains and represents the only member for which a
structural basis for chain recognition has been determined
(Sato et al., 2008).
MPN+ domain DUBs can act in isolation, as exemplified by
AMSH-LP, or in macromolecular assemblies to cleave poly
ubiquitin chains of varied linkage types. In protein complexes,
an MPN+ domain can associate with pseudo MPN domains
(MPN–) for purposes that are notwell understood.MPN–domains
are recognizable by the absence of essential Zn2+-coordinating
residues that are required for catalytic function. Established
MPN+–MPN– domain pairings include CSN5 and CSN6 in the
COP9 signalosome and RPN11 and RPN8 in the proteasome.
While the mode of MPN+–MPN– interaction is conserved be-
tween these two systems (Deshaies, 2014; Lingaraju et al.,
2014; Pathare et al., 2014; Worden et al., 2014), no precise
function has been ascribed to either MPN– domain, and neither
structure has been probed deeply for insights into how the
MPN– domain might support MPN+ domain function.
The importance of the MPN– subunit in BRISC and ARISC
minimally serves a 2-fold purpose, first to support DUB activity
and second to mediate protein–protein interactions. KIAA0157
and Abraxas are required for the catalytic function of BRCC36
in both complexes and enable association of two additional
shared subunits (BRCC45 and MERIT40) to each holoenzyme.
Moreover, BRCC36 interactions with KIAA0157 or Abraxas are
necessary for association with the holoenzyme specific adaptor
subunits, SHMT2 and RAP80, which target their respective DUB
complex to sites of K63-Ub synthesis.
In this study, we sought to address (1) the general architecture
of active BRCC36 DUB complexes, and (2) how subunit assem-
bly affects enzyme function. Toward this end, we have charac-
terized the binding architecture of BRISC and ARISC complexes
and solved the X-ray crystal structures of the minimally active
BRCC36–KIAA0157 heterodimer subcomplex and an inactive
BRCC36-BRCC36 homodimer complex. These studies revealed
that formation of an unanticipated higher-order super dimer is
essential for DUB activity and for protein interactions necessary
for the subcellular localization and biological function of each
BRCC36 complex.
RESULTS
Assembly Overview of the BRISC Complex
To probe the assembly architecture of BRISC and ARISC
complexes for downstream structure and function analyses,
we surveyed the expression of complete holoenzyme com-
plexes and subcomplexes in insect cells from a variety ofMolecumetazoan orthologs, including H. sapiens, X. laevis, G. gallus,
D. rerio, C. floridanus and A. thaliana (see Table S1 for a
summary of gene names and accession numbers). Using
the MultiBac expression system (Fitzgerald et al., 2006), we
expressed and purified DrBRCC36 and CfBRCC36 in isola-
tion, C. floridanus BRCC36–KIAA0157, BRCC36–KIAA0157–
BRCC45 and BRCC45–MERIT40 subcomplexes, and fully
intact C. floridanus, D. rerio, and H. sapiens BRISC and
the H. sapiens ARISC (BRCC36–Abraxas–BRCC45–MERIT40)
complexes at preparative levels, either as full-length proteins
or as trimmed deletion mutants optimized for crystallization;
Figure S1).
CfBRCC36 alone displayed no detectable cleavage activity
against a K63-linked diUb fluorigenic substrate in vitro (Fig-
ure 1A). However, when complexed with CfKIAA0157, the pro-
tein displayed robust DUB activity that was further enhanced
by the presence of CfBRCC45. Further addition of CfMERIT40
had no further effect on DUB activity. A similar trend of DUB acti-
vation was observed for zebrafish BRCC36 (Figure S1A), consis-
tent with prior studies on human BRCC36 (Cooper et al., 2010;
Feng et al., 2010; Patterson-Fortin et al., 2010). These results
support the notion that the underlying mechanism of BRCC36
regulation by subunit assembly displayed by human, ant, and ze-
brafish proteins is conserved throughout evolution.
Size exclusion chromatography coupled to multi-angle light
scattering analysis (SEC-MALS) of theC. floridanus BRISC com-
plex (Figure S1B), revealed a molecular weight of 256 kDa sug-
gestive of a 2:2:2:2 stoichiometry (a super dimer). Molecular
weights corresponding to super dimers were also observed
for human BRISC and ARISC complexes (Figure S1C) and for
the zebrafish BRISC complex (Figure S1D). To identify the sub-
unit(s) responsible for super dimerization, we subjected the
following subcomplexes to SEC-MALS analysis. The Cf and
Dr BRCC36–KIAA0157 binary complexes (131 and 130 kDa,
respectively), CfBRCC36–KIAA0157–BRCC45 triple complex
(188 kDa) but not the CfBRCC45–MERIT40 binary complex
(72 kDa) showed evidence of tight super dimerization (Figures
S1B and S1D). We were unable to produce CfKIAA0157 and
CfBRCC45 in isolation, and while CfBRCC36 was expressed at
appreciable levels, it eluted as an aggregate (Figure S1B).
DrBRC36 in isolation, however, was well behaved in solution
and displayed only a weak ability to form dimers (Figure S1E).
These results (summarized in Figures S1F and S1G)were consis-
tent with subunit assembly and stoichiometry models obtained
using mass spectrometry measurements on HsBRISC under
native conditions (Figures S2A–S2D).
Collectively, these data demonstrated several obligate pro-
tein folding relationships between MPN– proteins and BRCC36,
between BRCC45 and MERIT40 and between BRCC45 and
BRCC36/KIAA0157, suggestive of direct binding interactions
between subunits. They also indicated that both BRISC
and ARISC adopt a tight higher-order dimer configuration
through the core BRCC36–KIAA0157 and BRCC36–Abraxas
subcomplexes.
Determination of a BRCC36–KIAA0157 Co-structure
Wepursuedcrystallization ofBRCC36–KIAA0157 subcomplexes
fromdifferent species (H. sapiens,G. gallus,X. tropicalis,D. rerio,lar Cell 59, 970–983, September 17, 2015 ª2015 The Authors 971
Figure 1. Structure of the BRCC36–
KIAA0157 Complex
(A) Cleavage activity of CfBRCC36 and
CfBRCC36-containing complexes toward an
internally quenched K63-diUb fluorogenic sub-
strate. Results ±SEM are the average of three
independent experiments carried out in duplicate.
(B) Structure of the CfBRCC36–KIAA0157DC
complex. Contents of the asymmetric unit revealed
two CfBRCC36–KIAA0157DC complexes forming
a dimer of heterodimers (super dimer).
(C) Ribbon representation of the CfBRCC36–
KIAA0157DC heterodimer. Zoom in panels show a
detailed view of interacting residues. Disordered
regions are shown as dashed lines. Interacting
residues analyzed by mutation are labeled in red.
See also Figures S1–S4 and S6.C. floridanus, and A. thaliana) to determine the structural basis
for (1) how KIAA0157 supports the catalytic function of
BRCC36, and (2) how super dimerization of the minimally
active BRCC36–KIAA0157 heterodimer is mediated. Only
CfBRCC36–KIAA0157 yielded initial crystals, but these dif-
fracted poorly. Optimization of the CfKIAA0157 construct boun-
daries by deletion of poorly conserved C-terminal residues 290
to 471 (CfKIAA0157DC) yielded crystals in complex with full
length CfBRCC36 (residues 1–253) that diffracted to 2.55 A˚
resolution.
We solved the CfBRCC36–KIAA0157DC crystal structure
using the seleno-methionine-SAD method (see Experimental
Procedures for seleno-methionine protein production and crys-
tallographic details). Following manual rebuilding and refine-
ment, two highly interdigitated CfBRCC36–KIAA0157DC hetero-
dimers were apparent in the asymmetric unit, arranged in
the suspected super dimer configuration (Figure 1B). The final
model displayed good crystallographic and geometric statistics
(Rwork/Rfree = 0.189/0.240; see Table 1 for data collection and972 Molecular Cell 59, 970–983, September 17, 2015 ª2015 The Authorsrefinement statistics). Unbiased electron
density maps are shown in Figures S2E–
S2G and structure-based sequence
alignments of BRCC36 and KIAA0157DC
are shown in Figure S3.
Structure of theBRCC36–KIAA0157
Heterodimer
The structure of each protomer of
CfBRCC36 and CfKIAA0157 consisted
of a canonical MPN domain (residues
1–165 in BRCC36 comprising an eight
strand b sheet flanked by three a heli-
ces and residues 1–180 in KIAA0157
comprising a seven strand b sheet
flanked by three a helices), followed by
two non-canonical helices a4 and a5
within the predicted coiled-coil regions
(Figure 1 and Figure S3). CfBRCC36
and CfKIAA0157DC protomers hetero-
dimerized through a large buried sur-face area (SA) of 8,112 A˚2. The MPN domains of each
associated in a pseudo 2-fold manner centered on helices
a1 (Figure 1C), resulting in a unified b-sheet and ‘‘fused’’
MPN+–MPN– superstructure (buried SA = 2,902 A˚2). Non-ca-
nonical helices a4 and a5 of CfBRCC36 interacted with helices
a4 and a5 of CfKIAA0157 in the form of a coiled-coil helical
bundle (CCHB) (Figure 1C). The helical bundle was tethered
against the fused MPN domains of BRCC36 and KIAA0157
via a mixture of hydrophobic and hydrophilic interactions
(Figure 1C).
The contact surfaces between CfBRCC36 and CfKIAA0157
protomers were highly hydrophobic in nature, which may ac-
count for our inability to produce CfKIAA0157 alone and the
tendency of CfBRCC36 to form aggregates when expressed in
isolation (Figure S1B). Three large networks of hydrophobic in-
teractions were apparent, involving, first the MPN core domains
(Leu15, Ser16, Leu17, and Phe20 from KIAA0157 a1 helix, and
Tyr16, Met17, Leu20, and Leu24 from BRCC36 a1 helix), sec-
ond, the N-terminal end of the CCHB (Leu170, Thr174, and
Table 1. Summary of Data Collection and Structure Refinement
CfB36-KIADC CfB36-KIADC CfB36(QSQ)-KIADC DrBRCC36
Substitution None SeMet None None
Space Group P212121 P212121 P212121 P 6222
Wavelength 1.28240 A˚ 0.97920 A˚ 1.28270 A˚ 0.97920 A˚
Unit cell
a 49.9 A˚ 50.1 A˚ 89.4 A˚ 108.8 A˚
b 116.6 A˚ 116.3 A˚ 124.2 A˚ 108.8 A˚
c 226.1 A˚ 231.5 A˚ 132.5 A˚ 137.4 A˚
a = b 90 90 90 90
g 90 90 90 120
Molecules/asu
BRCC36 2 2 2 1
KIAA0157 2 2 2 –
Data processing and refinement
Resolution 2.55 A˚ (2.65–2.55 A˚) 2.54 A˚ (2.7–2.54 A˚) 2.75 A˚ (2.85–2.75 A˚) 3.2 A˚ (3.3–3.2 A˚)
Observed reflections 277,108 (30,610) 243,872 (39,265) 103,925 (9,417) 85,408 (7,589)
Unique reflections 80,922 (8,974) 84,223 (13,506) 37,786 (3,622) 8,474 (816)
Redundancy 3.4 (3.4) 2.9 (2.9) 2.8 (2.6) 10.1 (9.3)
I/sI 7.2 (1.0) 14.3 (1.1) 7.3 (0.8) 12.7 (1.5)
Completeness 97.3% (98.0%) 98.1% (97.3%) 95.8% (93.2%) 99.9% (99.9%)
Rmeas 0.123 (149.4) 0.059 (123.5) 0.158 0.201
CC1/2 (43.4%) (52.4%) (50.0%) (87.4%)
Rwork, Rfree 0.211, 0.259 0.189, 0.240 0.231, 0.277 0.214, 0.241
Average B-factor 76.5 A˚2 93.7 A˚2 72.9 A˚2 82.3 A˚2
RMSD from ideal geometry
Bonds 0.002 A˚ 0.003 A˚ 0.002 A˚ 0.002 A˚
Angles 0.505 0.554 0.493 0.527
Ramachandran plot statistics
Residues in favored region 97.0% 96.1% 98.2% 95.1%
Residues in allowed region 2.8% 3.8% 1.7% 4.9%
Residues in outlier region 0.2% 0.1% 0.1% 0.0%
PDB ID PDB: 5CW3 PDB: 5CW4 PDB: 5CW5 PDB: 5CW6
Values for high-resolution shells are shown in brackets. B36, BRCC36; KIAA, KIAA0157; QSQ, BRCC36 H94Q + H96Q mutant.Val181 from CfBRCC36 helix a4, and Met226, Leu236, Ile240,
Val243, and Cys244 from CfKIAA0157 helix a5), and lastly, the
C-terminal end of the CCHB (Arg229, Leu240, Leu244, and
Leu247 of CfBRCC36 helix a5 and Val243, Val250, Leu253,
Leu257, and Leu260 of CfKIAA0157 helix a5). A limited number
of H-bonding interactions were also observed between Asp247
and Gln229 of KIAA0157 with Asn233, Ser177, and Thr215 of
BRCC36 (Figure 1C).
The heterodimer configuration of BRCC36–KIAA0157 con-
trasted with the archetypal member AMSH-LP, which exists as
a simpleMPN+ domainmonomer (Figure 2A, left). It was also sur-
prisingly distinct from all known MPN+–MPN– dimer configura-
tions including the biologically relevant configuration shared by
CSN5–CSN6 (buried SA = 7697 A˚2; 4550 A˚2 for MPN domains
only) and RPN11–RPN8 (buried SA = 4,054 A˚2 for MPN domains
only) (Figures S4A and S4B, left), and the homodimer configura-
tions of unknown relevance displayed by other MPN proteins
(Figure S4C).MolecuStructure of the BRCC36–KIAA0157 Heterodimer Is
Functionally Relevant in Cells
To validate the BRCC36–KIAA0157 heterodimer as being re-
levant in cells, we mutated direct contact residues and as-
sessed interaction function of human BRCC36 and KIAA0157
by co-immunoprecipitation (see structure-based sequence
alignments in Figure S3 and Table S2 for a list of equivalent
residues mutated). The MPN+ mutation Leu27Arg alone or in
combination with Leu23Arg in BRCC36 disrupted binding to
KIAA0157, and in addition to MERIT40, BRCC45, SHMT2,
RAP80, BRCA1, and to a lesser extent Abraxas (Figure 3A). In
the reciprocal analysis, the MPN– domain mutation Ser11Arg
in KIAA0157 alone or in combination with Ala12Arg or Phe15Ser
also reduced interaction with BRCC36 and additionally with
MERIT40 and SHMT2 although to different extents (Figure 3B).
The KIAA0157 CCHB double (Val220Arg + Glu231Tyr) and
triple (Val220Arg + Glu231Tyr + Val241Tyr) mutations showed
more potently reduced interaction with BRCC36, MERIT40,lar Cell 59, 970–983, September 17, 2015 ª2015 The Authors 973
Figure 2. Catalytic and Substrate Binding
Infrastructure of the BRCC36–KIAA0157
Complex
(A) Left: comparison of the CfBRCC36 MPN
domain with AMSH-LP (PDB: 2ZNV). Right:
zoom in view of the superimposed active site re-
gions. All superpositions were performed using
Coot and coiled-coil regions were omitted for
simplicity.
(B) Surface representation of CfBRCC36 struc-
ture colored in shades of blue reflecting seq-
uence conservation across metazoan species
(see sequence alignment in Figure S3). The
binding of K63-linked diUb substrate was
modeled by superimposing the AMSH-LP–diUb
co-structure (PDB: 2ZNV) on the CfBRCC36
structure using the program Coot. Invariant res-
idues predicted to interact with distal and prox-
imal ubiquitins and selected for mutagenesis are
colored red.
(C) Cleavage activity of WT CfBRCC36–
KIAA0157DC and the indicated CfBRCC36 mu-
tants toward an internally quenched K63-diUb
fluorogenic substrate (left). Coomassie-stained
SDS-PAGE analysis of the indicated complexes
(right). Results ±SEM are the average of three in-
dependent experiments carried out in duplicate.
See also Figures S3 and S4.and SHMT2 (Figure 3B). Mutagenesis of the MPN– domain
of Abraxas, including Gly16Arg (analogous to Ser11 in
KIAA0157) disrupted interaction with BRCC36 and RAP80,
leaving interactions with BRCC45 and MERIT40 largely intact.
A second MPN– domain mutation, Phe20Ala, modestly re-
duced binding to BRCC36 and also to MERIT40, BRCC45,
and RAP80 (Figure 3C). Lastly, the CCHB mutation Glu237Tyr
in Abraxas potently disrupted binding to BRCC36 with only a
modest effect on RAP80 interaction (Figure 3C). These obser-
vations support the notion that the crystal structure of the
BRCC36-KIAA0157 heterodimer is reflective of both BRCC36-
KIAA0157 and the BRCC36-Abraxas interactions in cells and
that perturbation of heterodimerization has far-reaching conse-
quences on the assembly of other subunits.
To assess the consequence of perturbing BRCC36–
KIAA0157 heterodimerization on signaling function, we moni-
tored STAT1 phosphorylation at Tyr701 in response to Herpes
Simplex Virus (HSV) infection in KIAA0157–/– mouse embryonic974 Molecular Cell 59, 970–983, September 17, 2015 ª2015 The Authorsfibroblasts that had been reconstituted
with either WT human KIAA0157 or
the aforementioned KIAA0157 mutants.
HSV lacking the lytic phase gene ICP0
produces robust interferon dependent
JAK-STAT phosphorylation several hours
after infection of human or mouse cells.
KIAA0157–/– MEFs showed reduced
STAT1 phosphorylation (Figure 3D),
consistent with impaired type I interferon
signaling (Zheng et al., 2013). STAT1
phosphorylation was restored with intro-
duction of WT KIAA0157 but showedreduced activation in KIAA0157–/– cells expressing the MPN–
(Ser11Arg + Ala12Arg) mutant, or the CCHB single (Val220Arg)
or triple (Val220Arg + Glu231Tyr + Val241Tyr) mutant. Similarly,
BRCC36 MPN+ domain double mutant (Leu23Arg + Leu27Arg)
was impaired for IR-induced foci formation as was Abraxas
MPN– mutant (Gly16Arg) (Figure 3E; Figure S5). Since recruit-
ment to IR-induced DNA damage sites is dependent on interac-
tion with RAP80 and MERIT40 (Feng et al., 2009; Shao et al.,
2009; Wang et al., 2009), the observed loss of localization of
BRCC36 and Abraxas mutants was in agreement with the
reduced association of both mutants in co-IP experiments
(Figures 3A and 3C). Consistent with this notion, Abraxas mu-
tants Phe20Ala and Glu237Tyr that retain interaction with
RAP80 (Figure 3C) did not show a marked loss of IR-induced
foci formation (Figure S5). Together, these results support
the notion that the crystal structure of BRCC36–KIAA0157 re-
ported here reflects a functionally relevant mode of interaction
in cells.
Catalytic and Substrate Binding Infrastructure of
BRCC36
Consistent with our observation of robust catalytic function
in vitro, the active site residues in BRCC36 when complexed
to KIAA0157 resided in an active-like conformation shared by
AMSH-LP, CSN5, and RPN11 (Figure 2A; Figures S4A and
S4B, right). Productive features included the coordination of
a high occupancy Zn2+ ion by the triad of His94, His96, and
Asp107 side chains, the position of the transition state stabilizing
Ser104 side chain, and water-coordinating catalytic Glu30
side chain. The active-like orientation of these key residues
was supported by productive conformations of underlying sec-
ondary structure elements including strand b4 (denoted as the
H-strand for positioning His94 and His96), helix a3 (denoted as
the D-helix for positioning Asp107), the b4-a3 loop (denoted as
the S-loop for positioning Ser104), and the a1- b2 loop (denoted
E-loop for positioning Glu30).
With only one notable difference, the substrate recognition
infrastructure of BRCC36 appeared generally similar to that of
AMSH (Figures S4D–S4F), not unexpectedly since both display
a strong preference for cleaving K63 linked ubiquitin chains.
Indeed, the projected substrate contact site on BRCC36 is the
most highly conserved surface across BRCC36 orthologs (Fig-
ure 2B). As a matter of convention, for a DUB engaging a diUb
substrate of specific linkage type, the distal ubiquitin refers to
the protomer that contributes its C terminus, while the proximal
ubiquitin refers to the protomer that contributes the Lys residue
to the inter-ubiquitin isopeptide bond. AMSH-LP contains two
essential insertions, Ins-1 and Ins-2, that contribute substantially
to substrate contact (Sato et al., 2008). In AMSH-LP, Ins-1 con-
tacts both the distal ubiquitin (buried SA = 1,202 A˚2) and,
together with the short b4-a3 linker, the proximal ubiquitin
centered on the lysine 63 linkage site (buried SA = 630 A˚2)
(Figure S4E). In BRCC36, a similarly configured Ins-1 (residues
53–83 rigid body shifted 3.3 A˚ in the absence of substrate)
and b4-a3 linker (residues 97–104), were well positioned to
engage substrate in a K63-chain-specific manner (Figure S4E).
In AMSH-LP, Ins-2 mediates a smaller contact (buried SA =
387 A˚2) with the proximal ubiquitin protomer remote from the
K63 linkage site (Figure S4E). In BRCC36, the entire Ins-2module
was absent, with no possible compensatory contacts afforded
by KIAA0157 (Figure S4D).
To confirm our inference of the extended substrate-binding
surface on BRCC36, wemutated conserved residues on the pro-
jected distal ubiquitin (Met117) and proximal (Ile99) ubiquitin
contact sites and measured their effects on catalytic function
(Figure 2B; Figure S4F). Both Met117Ala and Ile99Arg mutants
were greatly compromised for DUB activity approaching the
complete loss of function resulting from an active site (Glu30Ala)
mutation (Figure 2C). Together, these results suggest that
despite lacking Ins-2, BRCC36 engages K63-linked diUb in a
manner generally similar to AMSH-LP.
Structural Role of Zn and Basis for KIAA0157 Lack of
Catalytic Function
KIAA0157 is predicted to lack catalytic function due to a defi-
ciency of active site residues required to coordinate the catalytic
Zn2+ ion (Maytal-Kivity et al., 2002). Consistent with this pre-Molecudiction, the projected active site region of CfKIAA0157 showed
no evidence of a bound Zn2+ ion (Figure 1; Figure S6A). We attri-
bute this to the substitution of the two essential Zn2+ coordi-
nating residues (His94 and His96 in CfBRCC36) with Cys101
and Arg103 in CfKIAA0157. We note that the third triad position
is maintained as Asp (position 115). Additional substitutions
that would contribute to a lack of catalytic function include the
substitution of the water-coordinating Glu side chain with Asn
(residue 28) and a subtle substitution of the catalytic Ser residue
with Thr (residue 112). Demonstrating that, in addition to a cata-
lytic role, the Zn2+ ion in BRCC36 also plays a major scaffolding
role, a BRCC36QSQ mutant compromised for Zn2+ ion binding
(harboring His94Gln and His96Gln mutations shown previously
to compromise DUB function in vitro and in cells [Patterson-For-
tin et al., 2010; Sobhian et al., 2007]), displayed extensive
structural distortions to the active site region, including disorder
of Ins-1, the S-loop, and the D-helix (Figure S6B). In contrast, the
corresponding elements were surprisingly ordered in KIAA0157.
This may be attributable, in part, to compensating salt interac-
tions in KIAA0157 involving the Arg103 and Asp115 projected
catalytic triad positions. Suggesting that KIAA0157 has also
dispensedwith the ability to bind ubiquitin substrate, the position
and sequence of Ins-1 in KIAA0157 deviated greatly from that in
BRCC36 (Figure S6A).
Mechanism by which KIAA0157 Supports BRCC36
Catalytic Function
To understand how KIAA0157 supports the catalytic function
of BRCC36, we set out to solve an inactive-state structure of
BRCC36 in isolation. Unlike CfBRCC36, which showed a pro-
pensity to aggregate at high protein concentrations, DrBRCC36
existed as a concentration dependent monomer-dimer in
equilibrium (Figure S1E) and readily crystallized (see Table 1
for data collection and refinement statistics). Interestingly,
DrBRCC36 adopted the analogous homodimer configuration
involving the MPN domain (buried SA = 1,693 A˚2) displayed by
the CfBRCC36-KIAA0157DC heterodimer (Figure 4A and Fig-
ures S7A and S7B for stereo view and combined sequence align-
ment), with the main exception that the CCHB helices a4 and a5
were completely disordered.
While the MPN+ domains of DrBRCC36 and CfBRCC36 were
highly similar (RMSD of 2.0 A˚ over 140 Ca atoms), notable differ-
ences in the active site region of DrBRCC36 were apparent that
might account for its lack of DUB activity in comparison to
CfBRCC36 complexed to KIAA0157. In particular, the E-loop
of the DrBRCC36 inactive structure was partially disordered
and shifted with respect to the CfBRCC36 active structure, giv-
ing rise to a 4–5 A˚ displacement of the catalytic glutamate (Glu30
in CfBRCC36; Glu27 in DrBRCC36) (Figure 4B). Suggesting that
this distortion was responsible in part for the loss of DUB activity
(and not simply a trivial consequence of sequence divergence
between ant and zebrafish proteins at 57% identity), the E-
loop and the catalytic Glu residue reside in the same productive
conformation in all depositedMPN+ X-ray structures that sample
great variations of sequence identity (as low as 19%), species of
origin (archaebacteria, yeast, zebrafish, and human) and sub-
strate specificity (ubiquitin versus Nedd8 cleaving enzymes)
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Figure 3. BRCC36–KIAA0157 Interaction Is Important for Signaling in Cells
(A) Immunoprecipitation (IP) was performed using anti-Flag antibody in 293T cells that had been transiently transfected with Flag-HA epitope-tagged BRCC36
wild-type (WT) or mutants. Immunoblot was performed using antibodies to the indicated BRISC and ARISC components.
(B and C) Flag-IP was performed for Flag-HA-KIAA0157 or Abraxas in transiently transfected 293T cells as in (A). Immunoblot was performed for selected
members of the BRISC or ARISC as indicated to determine the impact of the various mutants tested on protein-protein interactions.
(D) KIAA0157–/– MEFs and KIAA0157–/– MEFs reconstituted with WT or the indicated mutants were infected with Herpes Simplex Virus (HSV) deleted for the lytic
phase gene ICP0. Interferon receptor-dependent signal transduction response was assessed by immunoblot for STAT1 phosphorylated at Y701 (Pi-STAT1).
(legend continued on next page)
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Figure 4. Comparison of the BRCC36 Ho-
modimer and BRCC36–KIAA0157 Hetero-
dimer
(A) Comparison of the DrBRCC36 homodimer (top)
with the CfBRCC36–KIAA0157DC heterodimer
(bottom) reveals similarities in MPN domain asso-
ciation but disorder of the helical bundle region.
(B) Zoom in of the active site region of CfBRCC36
(blue) superimposed on DrBRCC36 (wheat). The
CfKIAA0157DC subunit complexed to CfBRCC36
has been omitted for clarity. Active site residues
are shown as sticks and Zn2+ atoms and a catalytic
water molecule are represented as spheres.
Disordered regions are shown as curved dashed
lines. See also Figures S2, S3, and S7.Additionally, a major portion of Ins-1 was disordered and the
ordered portion (helix a2) was shifted relative to the correspond-
ing position in CfBRCC36 (Figure 4B). Both of these structural
distortions may be attributable to the loss of supporting inter-
actions afforded by heterodimerization of CfBRCC36 with
CfKIAA0157, as follows. First, in the active heterodimer struc-
ture, a productive conformation of CfBRCC36 Ins-1 appears
supported by direct contacts to CfBRCC36 helix a4, including
between the invariant Arg53 (Ins-1) and Asp186 (a4) side chains
and between the backbone carbonyl of Arg53 (Ins-1) and the
invariant Glu183 (a4) side chain (Figures 5A and 5B; Figure S3A).
The absence of the CCHB elements (specifically helix a4) in the
inactive structure precluded formation of these interactions.
Consistent with this inference, mutation of both Glu183 and
Asp186 to alanine, selectively disabled CfBRCC36–KIAA0157
catalytic function (Figure 5C; Figures S7D and S7E). Second, a
productive conformation of the E-loop, and in effect Glu30 of
CfBRCC36, appears supported by direct contacts to the b7-a4
loop (residues 177–203) within the MPN– domain of CfKIAA0157
(Figures 5B and 5D). We refer to this contact site on KIAA0157 as
the E-loop supporting element. Specific interactions included
between the invariant side chain of CfBRCC36 Glu27 and the
backbone of Lys174 and Asn177 of CfKIAA0157 and between
the backbone of CfBRCC36 Ser25 and CfKIAA0157 Leu178
(Figures 5B and 5D). Supporting the notion that these inter-
actions have bearing on protein function, mutation of Asn177
to Arg in CfKIAA0157 selectively disabled CfBRCC36–
KIAA0157 DUB activity (Figure 5C; Figures S7D and S7E). The
position of the E-loop supporting element also appears to be
aided by contacts between His213 and Ile217 in CfBRCC36
CCHB helix a5 and Leu178 of CfKIAA0157 (Figure 5D). Intrigu-
ingly, the E-loop supporting element of CfKIAA0157 also ap-(E) Dual color immunofluoresence using antibodies against HA and gH2AX was performed at 6 hr after 10 G
BRCC36 or Flag-HA-Abraxas. Co-localization of WT BRCC36 or WT Abraxas with gH2AX indicates succ
BRCC36 (L23R + L27R) or Abraxas (G16R) mutants failed to show foci formation and colocalization with gH
Figures S4 and S5.
Molecular Cell 59, 970–983, Sepears buttressed by interactions with
CCHB helices a4 and a5 of CfBRCC36
from an opposing CfBRCC36–KIAA0157
heterodimer within the framework of the
higher-order super dimer (Figures 5B
and 5D). These observations suggested a potential role for super
dimerization in the attainment of the CfBRCC36 active state, a
hypothesis we test below.
Structural Features of the BRCC36–KIAA0157DC Super
Dimer
Within the crystal environment, the functionally validated
CfBRCC36–KIAA0157 heterodimer made four major contacts
(>700 A˚2) with surrounding heterodimers that we reasoned
could be responsible for super dimerization in solution (Fig-
ure S8A). We collected small angle X-ray scattering data of
the CfBRCC36–KIAA0157DC heterodimer at three different
concentrations. The molecular weight of the complex calcu-
lated from the scattering curve was 126 kDa (Rambo and
Tainer, 2013), consistent with the formation of a super dimer.
Ab initio modeling and comparison of the calculated scat-
tering curves for the heterodimer and the four possible super
dimers with the experimental data using CRYSOL (Svergun
et al., 1995) was most consistent with the 2-fold symmetric
super dimer configuration centered on CfBRCC36 helix a5
that buried 3,093 A˚2 of surface area (Figures S8B–S8D; Fig-
ure 6A). Contacts were predominantly hydrophobic in nature
involving reciprocal patches composed by Leu198, Ile201,
Ala205, and Ile212 side chains on opposing CfBRCC36 pro-
tomers (Figure 6A). Additional interactions were provided by
loop b7-a4 of KIAA0157 (E-loop supporting element), most
notably the invariant Tyr190 side chain, which inserted into
a hydrophobic pocket between a4 and a5 and formed a
hydrogen bond with the invariant Glu184 side chain of
CfBRCC36 from the opposing heterodimer (Figure 6A).
Finally, residues Arg209 (CfBRCC36) and Asp189
(CfKIAA0157) from the same heterodimer formed a salt bridgey IR in MEFs that stably expressed either Flag-HA-
essful recruitment to DNA double-strand breaks.
2AX. Quantification is shown in Figure S5. See also
ptember 17, 2015 ª2015 The Authors 977
Figure 5. The Active Site Conformation of BRCC36 Is Dependent on Heterodimerization with KIAA0157
(A) Zoom in comparison of the heterodimer interface of the CfBRCC36–KIAA0157DC complex (blue–green) superimposed on the homo dimerization interface of
DrBRCC36 (wheat). The Ins-1 loop (cyan) of CfBRCC36 contacts helix a4 (blue) within the coiled-coil helical bundle region (CCHB; highlighted by pink oval). Both
regions in the DrBRCC36 homodimer are disordered. The E-loop of CfBRCC36 and E-loop supporting element of CfKIAA0157 are colored orange and green,
respectively. Disordered regions are shown as curved dashed lines.
(B) Schematic of inter-subunit interactions shown in (A) and (D) that support a productive conformation of theBRCC36 active site. The integrity of the helical bundle
involving helices a4 and a5 of BRCC36 and KIAA0157 is dependent on BRCC36–KIAA0157 heterodimerization. Within one protomer of BRCC36, the Ins-1 loop is
buttressed by contacts with helix a5. Across the BRCC36–KIAA0157 heterodimer, the E-loop of BRCC36 is buttressed by contacts with the ‘‘E-loop supporting
element’’ of KIAA0157. The ‘‘E-loop supporting element’’ of KIAA0157 in turn is buttressed by contacts with helices a4 and a5 within the BRCC36–KIAA0157
heterodimer and also across the super dimer of BRCC36–KIAA0157 heterodimers. For clarity, detailed features are only drawn on one heterodimer. Not to scale.
(C) Cleavage activity of the WT CfBRCC36–KIAA0157DC complex and the indicated mutants toward an internally quenched K63-diUb fluorogenic
substrate. Coomassie-stained SDS-PAGE and SEC-MALS analysis of the indicated complexes are shown in Figures S7D and S7E. Results ±SEM are
the average of three independent experiments carried out in duplicate.
(D) Zoom in view of the heterodimer and super dimer interface of the CfBRCC36–KIAA0157DC complex (blue-green). The E-loop (orange) of CfBRCC36 contacts
the E-loop supporting element (green) of CfKIAA0157. The E-loop supporting element of CfKIAA0157 in turn contacts the CCHB (specifically helix a5) of
CfBRCC36 (denoted as protomer 1). In addition, the E-loop supporting element of CfKIAA0157 also makes contact to the CCHB of CfBRCC36 (purple-denoted
protomer 2), of a second CfBRCC36-KIAA0157 heterodimer arranged in the super dimer configuration shown in Figures 1B and 6A. Disordered regions in the
DrBRCC36 MPN+ domain are shown as curved dashed lines. See also Figures S3, S7, and S8.
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that tethered helix a5 of BRCC36 and the E-loop supporting
element of CfKIAA0157.
A Super Dimer of BRCC36–KIAA0157 Is Required for
DUB Activity In Vitro and Biological Function in Cells
BRCC36DUBactivity requires heterodimerizationwithKIAA0157.
Todetermine the importanceof theobservedhigher-orderassem-
bly to this minimally active heterodimeric pair, we generated
point mutations predicted to disrupt super dimerization without
directly impacting on heterodimerization. As assessed by SEC-
MALS, in contrast to the WT CfBRCC36–KIAA0157DC complex,
which eluted as a single peak with measured MW of 121.4 kDa
corresponding to a super dimer (Figures S8E–S8G), the double
CfBRCC36 mutant Ala205Asp + Ile212Asp eluted predominantly
as a monomer of heterodimers (85% major peak; MW =
66.8 kDa) with only a minor fraction eluting as super dimers
(15% minor peak; MW = 118.3 kDa). The single site mutants
Ala205Asp and Ile212Asp of CfBRCC36 displayed intermediate
behaviors with 70% and 36% of proteins, respectively, eluting
as monomers of heterodimers (Figures S8E–S8G). These obser-
vations validate the mode of dimerization via BRCC36 helix a5
observed in the crystal structure (Figure 6A) as relevant for super
dimerization in solution.
We next assayed WT and the super dimerization interface
mutants for the ability to cleave a K63-linked diUb fluorigenic
substrate in vitro (Figure 6B). In contrast to WT CfBRCC36–
KIAA0157DC, which displayed robust enzyme activity, the
double Ala205Asp + Ile212Asp BRCC36 mutant was completely
devoid of DUB activity, and the single site mutants Ala205Asp
and Ile212Asp mutants were 10-fold less active than WT
at near saturating substrate concentrations (>10 mM diUb;
Figure 6B). In addition, the single site mutants displayed evi-
dence of substrate inhibition, which when modeled, allowed
the determination of full kinetic parameters (Figure 6B). These
results showed that BRCC36 and KIAA0157 form a previously
undescribed super dimer centered on BRCC36 helix a5 that is
required for DUB activity in vitro and that may influence substrate
recognition properties.
To test whether super dimer formation occurred in the context
of a cellular environment, Flag-HA-human BRCC36 and a5
single mutants Ser266Asp, Cys273Asp, or the double mutant
Ser266Asp + Cys273Asp (Table S2) were stably expressed in
HeLa S3 cells (and transiently expressed in HEK293T cells)
and immunoprecipitated to assess interaction with endogenous
BRCC36. Consistent with super dimer formation in cells, WT
BRCC36 pulled down endogenous BRCC36, and this interaction
was reduced for either single site mutant and almost eliminated
for the double site mutant of BRCC36 (Figure 6C). Interestingly,
requirements for super dimer formation were subtly different be-
tween the BRISC–SHMT2 and ARISC–RAP80 complexes (Fig-
ure 6D). The double BRCC36 mutant maintained all monomeric
interactions in BRISC but failed to show interferon induced inter-
action with SHMT2. Conversely, the double mutant failed to
interact with Abraxas, BRCA1, and RAP80 and, as predicted,
did not form foci in response to IR (Figure 6E; Figure S5A). More-
over, consistent with the loss of DUB activity and interaction with
SHMT2, expression of the Ser266Asp, Cys273Asp, or the double
Ser266Asp + Cys273Asp mutants in MEFs showed reducedMolecuSTAT1 phosphorylation in response to HSV infection (Figure 6F).
These findings revealed that super dimer formation has a multi-
functional purpose: it is required for enzymatic activity and for
association with the targeting elements SHMT2 and RAP80.
Abrogation of super dimer formation thus eliminates BRCC36
DUB activity in vitro and biological function in cells.
Implications of Super Dimerization on Substrate Binding
The revelation of substrate inhibition-like behavior by the
Ala205Asp and Ile212Asp single site mutants led us to investi-
gate how a super dimer of BRCC36–KIAA0157 heterodimers
might influence the engagement of K63-linked diUb substrate.
Docking of K63 linked diUb substrate onto the BRCC36-
KIAA0157 super dimer revealed a close approach of 7 A˚ be-
tween the proximal Ub and the opposing BRCC36 protomer
across the super dimer (Figure 7A). We reasoned that a subtle
repositioning of the proximal ubiquitin moiety relative to the
substrate bound AMSH-LP structure could afford unique
and essential binding contacts for substrate engagement by
BRCC36. To test this hypothesis, we compared the binding affin-
ity of WT and a super dimer breaker mutant of BRCC36 to a
fluorescently labeled K63 diUb substrate (Figure 7B) using a fluo-
rescence polarization (FP) assay. To prevent cleavage of the
fluorescent probe, we employed the E30A mutation within the
catalytic site of both proteins. WT BRCC36(E30A)-KIAA0157DC
complex bound substrate with aKd of 2.4 ± 0.6 mM (Figure 7C), in
close agreement with the observed Km of 4.2 mM (Figure 6B).
Binding to the fluorescent probe was competed by unlabeled
K63 linked diUb and to a lesser degree mono ubiquitin (IC50 of
6.4 versus 74 mM) but not K48 linked diUb (Figure 7D), consistent
with the known specificity of the enzyme. The dimer breaker
mutant complex BRCC36 (E30A+A205D+I212D)-KIAA0157DC
showed no impairment of binding to K63 linked substrate (Kd
of 2.2 ± 1.0 mM; Figure 7C), ruling out essential contributions
across the super dimer for substrate engagement. Together
with the aforementioned conservation and mutational analyses
(Figures 2B and 2C), these data support a model for substrate
recognition by BRCC36 that is similar to AMSH-LP. Interestingly,
engagement of diUb at both BRCC36 active sites would lead to a
major steric clash (32% volume overlap) that could only be alle-
viated by a wholesale repositioning of the proximal ubiquitins
(Figure 7E).We reason that this conflict might prohibit concurrent
binding of substrate to both BRCC36 protomers within a super
dimer.
DISCUSSION
Our protein expression and co-purification studies on ARISC
and BRISC in insect cells, native mass spectrometry analysis
of HsBRISC, crystallographic and SAXS analyses on the
CfBRCC36–KIAA0157 complex, mutational and (in vitro and
cellular) functional studies on ARISC and BRISC support the
minimal architecture model for BRISC shown in Figure S2
(boxed). This model is applicable to ARISC with only the substi-
tution of the paralogous subunit of KIAA0157 with Abraxas (40%
identity, 65% similarity). Two BRCC36–KIAA0157 heterodimers
assemble as a higher-order super dimer at the center of the ho-
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Figure 6. The Super Dimer Configuration of BRCC36–KIAA0157 Heterodimers Is Essential for Function
(A) Ribbons view of a higher-order dimer configuration (super dimer) of CfBRCC36–KIAA0157DC heterodimers. Zoom in panel shows a detailed view of inter-
acting residues. Residues in red were mutated to test their contribution to super dimer formation.
(B) Michaelis-Menten kinetic analysis for cleavage of K63 diUb of wild-type (44 nM) and the indicated super dimer formation defective mutants (35 nM) of
CfBRCC36–KIAA0157DC. Results ±SEM are the average of three independent experiments carried out in duplicate.
(C) Flag-IP was performed in stably expressing HeLa S3 cells (top) or transiently transfected 293T cells (bottom) with either WT BRCC36 or super dimer defective
mutants S266D, C273D, and S266D + C273D. Immunoblot shows both ectopic and endogenous BRCC36 species from the co-IP for WT BRCC36, indicating
multimerization. Reduced or absent association with endogenous BRCC36 was observed for the single and double mutated ectopic BRCC36.
(legend continued on next page)
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Figure 7. Binding of BRCC36–KIAA0157DC
to K63-Linked diUb Is Not Dependent on Su-
per Dimerization
(A) Modeling of K63-linked diUb to BRCC36 using
the AMSH-LP–diUb co-structure (PDB: 2ZNV) as
template.
(B) Schematic of K63-linked diUb covalently
coupled to AlexaFluor-488.
(C) Left: interaction of BRCC36 (E30A)–
KIAA0157DC to the K63-linked diUb tracer (10 nM)
as determined by fluorescence polarization (FP).
Kd value ± SEM is the average of three indepen-
dent experiments carried out in duplicate. Middle:
interaction of BRCC36 (E30A+A205D+I212D)–
KIAA0157DC (super dimer breaker mutant) to the
K63-linked diUb tracer (10 nM) as determined by
fluorescence polarization (FP). Kd value ± SEM is
the average of two independent experiments car-
ried out in duplicate. Right: Coomassie-stained
SDS-PAGE analysis of the indicated CfBRCC36–
KIAA0157DC complexes. DD, CfBRCC36 A205D +
I212D mutation.
(D) Displacement of Alexa Fluor 488-labeled K63-
linked diUb tracer by unlabeled K63-diUb, Mono-
Ub, and K48 diUb. Results ± SEM are the average
of three independent experiments carried out in
duplicate.
(E) Modeling of concurrent binding of diUb to
opposing BRCC36 protomers within a BRCC36-
KIAA0157 super dimer leads to a 32% volume
overlap between proximal ubiquitin moieties.(as inferred bymass spectrometry Figure S2B, red oval), which in
turn recruits a MERIT40 subunit.
The pseudo DUBs KIAA0157 and Abraxas are required for the
catalytic function of BRCC36. Comparison of the BRCC36–
KIAA0157 heterodimer structure with an inactive BRCC36
homodimer structure provides a model for understanding how
this functional interplay is achieved. As shown in schematic
form in Figure 5B, the binding of KIAA0157 to BRCC36 is
required for stabilization of (1) the CCHB, (2) the E-loop of
BRCC36 and optimal positioning of the catalytic glutamate
side chain for catalysis, and (3) the Ins-1 loop of BRCC36 and
its proper positioning for substrate binding. Stabilization of all
three elements is supported through direct interactions between
KIAA0157 and BRCC36 within a single heterodimer as well as(D) Flag-IP was performed on HeLa S3 cells stably expressing epitope-tagged BRCC36 WT or mutants from
assess interactions with the indicated members of BRISC and ARISC complexes.
(E) Co-localization of WT and S266D + C273D BRCC36 mutants with gH2AX in MEFs at 6 hr after 10
recruitment to DNA double-strand breaks. Super dimer defective mutant S266D + C273D failed to exhibit IR
Figure S5.
(F) MEFs were stably transduced with Flag-HA- WT BRCC36 or the indicated super dimer formation defec
immunoblot for Pi-STAT1 was performed as in Figure 3C to determine the impact on interferon signaling. S
Molecular Cell 59, 970–983, Sethrough interactions across BRCC36–
KIAA0157 heterodimers within a super
dimer. Despite the modeled vicinity of
the proximal ubiquitin moiety to the
opposing BRCC36 protomer within the
super dimer (Figure 7A), our data demon-strate that super-dimerization does not contribute positively to
substrate recognition (Figure 7C).
In addition to supporting the catalytic function of BRCC36,
KIAA0157 and Abraxas also serve scaffolding functions to
recruit the BRCC45–MERIT40 heterodimer and the targeting
subunits RAP80 or SHMT2. Surprisingly, super dimerization is
not only required for the catalytic function of BRCC36 but it
is also required for the binding of SHMT2 and RAP80/BRCA1
to BRISC and ARISC. It is also evident frommodeling and muta-
tional studies that super dimerization of BRISC/ARISC may
impinge on enzyme function by restricting substrate binding
to only one BRCC36 protomer in the super dimer at one time
(Figure 7E). These inter-dependencies of structure and function
provide intriguing potential for enzyme regulation and we(C). Immunoblot was subsequently performed to
Gy IR. Foci that colocalize with gH2AX indicate
induced foci formation. Quantification is shown in
tive mutants. Infection with HSV lacking ICP0 and
ee also Figures S1–S3 and S8.
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speculate they may be responsible, in part, for the pronounced
sensitivity to substrate inhibition displayed by the Ala205Asp
and Ile212Asp single site dimer breaker mutants (Figure 6B).
The apparent obligate folding dependency of KIAA0157 and
Abraxas on BRCC36 that we observed in insect cells hints that
the heterodimer interaction is constitutive and may not require
post-translationalmodifications.However, thesuperdimerization
of BRISC (and by extension ARISC)may be regulated in principle,
since mutations that drive a monomer state are well tolerated in
our insect cell expression studies with no evidence of protein ag-
gregation. If BRISC transitions between an inactivemonomer and
active dimer states, and only the dimer state can recognize the
targeting elements SHMT2 and RAP80, this would provide a tight
mechanism to couple enzyme activation with the recruitment to
biologically relevant substrates. How might super dimerization
be regulated? Others have shown that residues in the BRCC36
E-loop and in the KIAA0157 E-loop supporting element are phos-
phorylated in cells (Phosida database [Gnad et al., 2011]). Phos-
phorylation at these sites is well placed to affect catalytic function
directly or indirectly by influencing super dimerization.
Since super dimerization involves contributions of both
KIAA0157/Abraxas and BRCC36 subunits, it may be possible
to differentially regulate ARISC and BRISC enzyme activity with
small molecules by specifically targeting the MPN– subunit.
This would permit selective intervention on ARISC biological
function in the DNA damage response or BRISC involvement in
inflammatory cytokine signaling, even though the two holoen-
zymes share the same catalytic subunits. Additionally, although
both complexes share a common architecture, the relative
contribution and strength of the component interactions within
ARISC and BRISC differ to some degree, as evidenced by our
mutational studies in cells. Moreover, KIAA0157 is sufficient to
impart DUB activity to BRCC36, while Abraxas and BRCC45
are both necessary for minimal DUB activity in ARISC (Cooper
et al., 2010; Feng et al., 2010; Patterson-Fortin et al., 2010).
These differences in function might also be exploited for selec-
tive intervention by small molecules.
Consistent with a clear separation of biological function be-
tween ARISC and BRISC in cells, mutations in BRCC36 and
Abraxas are prevalent in cancer genomes whereas mutations
in KIAA0157 are rare. A survey of the Catalogue of Somatic
Mutations in Cancer (COSMIC) consortium, revealed that to
date, 37 substituting mutations were mapped to BRCC36
(>15,000 samples sequenced) and 35 to Abraxas (>19,000
samples sequenced), while only 1 mutation was mapped to
KIAA0157 (>19,000 samples sequenced) (Table S3). The muta-
tions in BRCC36 and Abraxas map to both MPN and CCHB do-
mains (and additionally for Abraxas, the regulatory C-terminal
tail, deleted in the KIAA0157 crystallization construct) and
encode both single site amino acid substitutions and trunca-
tions, many of which would be predicted to cause loss of protein
function. In contrast, only one mutation mapped to KIAA0157,
and it resided outside theMPN and CCHB domain without a pre-
dictable effect on function. These observations demonstrate a
strong selection for the loss of ARISC function in cancers and
conversely, no specific selection against BRISC function.
In terms of a broader perspective on DUB regulation, it is
fascinating that many multi-subunit DUBs contain two different982 Molecular Cell 59, 970–983, September 17, 2015 ª2015 The AutMPN domain proteins. This feature is reminiscent of a subset of
eukaryotic protein kinases, which employ dimerization to allo-
sterically regulate their enzyme activity. Considerable diversity
is displayed in how different protein kinase families dimerize,
ranging from side-to-side, back-to-back, and head-to-tail con-
figurations of kinase domains displayed by the RAF, eIF2a, and
EGFR families (Lavoie et al., 2014). This diversity reflects differ-
ences in the underlying modes of catalytic regulation. In the
case of the RAF family and EGFR family kinases, specific mem-
bers like KSR and HER2, respectively, have dispensed with
catalytic function altogether, while maintaining the ability to
transactivate other family members through dimerization (Lav-
oie et al., 2014). These specific examples parallel the operation
of MPN+–MPN– paired DUBs. We see that BRCC36 (MPN+)
heterodimerizes with the MPN– pseudo DUBs KIAA0157 or
Abraxas using a mode of interaction that is very different
from that of the CSN5–CSN6 and RPN8–RPN11 heterodimers.
This likely reflects the fact that the mechanism by which
KIAA0157/Abraxas support BRCC36 will differ from how
CSN6 and RPN8 support/regulate the function of CSN5 and
RPN11. As approximately 10% of DUBs are predicted to be
pseudo DUBs (Nijman et al., 2005), more examples of DUBs
regulated by inactive pseudo DUBs are likely to emerge. Under-
standing the scope of DUB–pseudo DUB pairings may reveal
new insights into how these important enzymes are regulated
and how they achieve isopeptide hydrolysis.EXPERIMENTAL PROCEDURES
General Methods and Buffers
Restriction enzyme digests, DNA ligations, and other recombinant DNA proce-
dures were performed using standard protocols. Mutagenesis was performed
using theQuikChange site-directedmutagenesis method (Stratagene) with the
KOD polymerase (Novagen). DNA constructs used for transfection were puri-
fied from E. coli DH5a using QIAGEN Plasmid kits according to the manufac-
turer’s protocol. All DNA constructs were sequence verified. Lysis buffer used
for purifying proteins from insect cells was composed of 50 mM Tris-HCl (pH
7.6), 300 mM NaCl, 20 mM imidazole, 5% (v/v) glycerol, 0.075% (v/v) 2-mer-
captoethanol, 1 mM benzamidine, 1 mM PMSF. Lysis buffer was supple-
mented with SigmaFast protease inhibitors (EDTA-free) at 1 tablet/100 ml
(Sigma). Wash buffer A was the same as lysis buffer without PMSF and prote-
ase inhibitors. High salt wash buffer B was the same as buffer A with 500 mM
NaCl. All protein concentrations were calculated using the Beer-Lambert law
by measuring the absorbance at 280 nm. Theoretical extinction coefficients
were calculated using the ProtParam tool at the ExPASy proteomics server
(http://www.expasy.org).
See Supplemental Information for a detailed description of the methods and
materials used in this study.ACCESSION NUMBERS
The accession numbers for the CfBRCC36-KIAA0157 (WT), SeMet
CfBRCC36-KIAA0157 (WT), CfBRCC36-KIAA0157 (QSQ mutant), and
DrBRCC36 structures reported in this paper have been deposited in the Pro-
tein Data Bank under ID codes PDB: 5CW3, 5CW4, 5CW5, and 5CW6.SUPPLEMENTAL INFORMATION
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